An update on bone substitutes for spinal fusion

Creative Commons License

Miyazaki M., Tsumura H., Wang J. C., ALANAY A.

EUROPEAN SPINE JOURNAL, cilt.18, sa.6, ss.783-799, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 18 Sayı: 6
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s00586-009-0924-x
  • Dergi Adı: EUROPEAN SPINE JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.783-799
  • Anahtar Kelimeler: Bone substitutes, Spinal fusion, Demineralized bone matrix, Bone morphogenic protein, Gene therapy, LUMBAR INTERBODY FUSION, ILIAC CREST AUTOGRAFT, OP-1 PUTTY RHBMP-7, ANTERIOR CERVICAL DISKECTOMY, BETA-TRICALCIUM PHOSPHATE, INSTRUMENTED POSTEROLATERAL FUSIONS, ADOLESCENT IDIOPATHIC SCOLIOSIS, AUTOLOGOUS GROWTH-FACTORS, LENTIVIRAL GENE-THERAPY, MESENCHYMAL STEM-CELLS
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

With the current advances in spinal surgery, an understanding of the precise biological mechanism of each bone substitute is necessary for inducing successful spinal fusion. In this review, the categories of bone substitutes include allografts, ceramics, demineralized bone matrix, osteoinductive factors, autogenous platelet concentrate, mesenchymal stem cells, and gene therapy. Further, clinical studies have been evaluated by their levels of evidence in order to elucidate the precise effect of the bone substitute employed and to establish clinical guidance. This article will review both clinical studies based on evidence and basic research in current advances in order to avoid as far as possible any chances of failure in the future and to understand cellular biology in novel technologies.